Literature DB >> 11152515

Characterization of recombinant hepatitis A virus genomes containing exogenous sequences at the 2A/2B junction.

M R Beard1, L Cohen, S M Lemon, A Martin.   

Abstract

Hepatitis A virus (HAV) differs from other members of the family Picornaviridae in that the cleavage of the polyprotein at the 2A/2B junction, commonly considered to be the primary polyprotein cleavage by analogy with other picornaviruses, is mediated by 3C(pro), the only proteinase encoded by the virus. However, it has never been formally demonstrated that the 2A/2B junction is the site of primary cleavage, and the actual function of the 2A sequence, which lacks homology with sequence of other picornaviruses, remains unknown. To determine whether 2A functions in cis as a precursor with the nonstructural proteins, we constructed dicistronic HAV genomes in which a heterologous picornaviral internal ribosome entry site was inserted at the 2A/2B junction. Transfection of permissive FRhK-4 cells with these dicistronic RNAs failed to result in the rescue of infectious virus, indicating a possible cis replication function spanning the 2A/2B junction. However, infectious virus was recovered from recombinant HAV genomes containing exogenous protein-coding sequences inserted in-frame at the 2A/2B junction and flanked by consensus 3C(pro) cleavage sites. The replication of these recombinants was less efficient than that of the parent virus but was variable and not dependent upon the length of the inserted sequence. An HAV recombinant containing a 420-nt insertion encoding the bleomycin resistance protein Zeo was stable for up to five passages in cell culture. Inserted sequences were deleted from replicating viruses, but this did not result from homologous recombination at the flanking 3C(pro) cleavage sites, since the 5' and 3' segments of the inserted sequence were retained in the deletion mutants. These results indicate that the HAV polyprotein can tolerate an insertion at the 2A/2B junction and that the 2A polypeptide does not function in cis as a 2AB precursor. Recombinant HAV genomes containing foreign protein-coding sequences inserted at the 2A/2B junction are novel and potentially useful protein expression vectors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11152515      PMCID: PMC114048          DOI: 10.1128/JVI.75.3.1414-1426.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

Review 1.  RNA recombination in animal and plant viruses.

Authors:  M M Lai
Journal:  Microbiol Rev       Date:  1992-03

2.  Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: evidence for genetic recombination.

Authors:  S M Lemon; P C Murphy; P A Shields; L H Ping; S M Feinstone; T Cromeans; R W Jansen
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

3.  Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus.

Authors:  J I Cohen; B Rosenblum; J R Ticehurst; R J Daemer; S M Feinstone; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

4.  Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture.

Authors:  J I Cohen; J R Ticehurst; S M Feinstone; B Rosenblum; R H Purcell
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

5.  Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles.

Authors:  D A Anderson; B C Ross
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

6.  Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence.

Authors:  M D Ryan; A M King; G P Thomas
Journal:  J Gen Virol       Date:  1991-11       Impact factor: 3.891

7.  Sequence and structural elements that contribute to efficient encephalomyocarditis virus RNA translation.

Authors:  G M Duke; M A Hoffman; A C Palmenberg
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

8.  Cardioviral internal ribosomal entry site is functional in a genetically engineered dicistronic poliovirus.

Authors:  A Molla; S K Jang; A V Paul; Q Reuer; E Wimmer
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

9.  Preferred sites of recombination in poliovirus RNA: an analysis of 40 intertypic cross-over sequences.

Authors:  A M King
Journal:  Nucleic Acids Res       Date:  1988-12-23       Impact factor: 16.971

10.  Detection and characterization of subgenomic RNAs in hepatitis A virus particles.

Authors:  J Nüesch; S Krech; G Siegl
Journal:  Virology       Date:  1988-08       Impact factor: 3.616

View more
  11 in total

1.  Stable growth of wild-type hepatitis A virus in cell culture.

Authors:  Krishnamurthy Konduru; Gerardo G Kaplan
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors.

Authors:  S Crotty; C J Miller; B L Lohman; M R Neagu; L Compton; D Lu; F X Lü; L Fritts; J D Lifson; R Andino
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Replication of subgenomic hepatitis A virus RNAs expressing firefly luciferase is enhanced by mutations associated with adaptation of virus to growth in cultured cells.

Authors:  MinKyung Yi; Stanley M Lemon
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  Evolutionary origins of hepatitis A virus in small mammals.

Authors:  Jan Felix Drexler; Victor M Corman; Alexander N Lukashev; Judith M A van den Brand; Anatoly P Gmyl; Sebastian Brünink; Andrea Rasche; Nicole Seggewiβ; Hui Feng; Lonneke M Leijten; Peter Vallo; Thijs Kuiken; Andreas Dotzauer; Rainer G Ulrich; Stanley M Lemon; Christian Drosten
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

5.  Analysis of deletion mutants indicates that the 2A polypeptide of hepatitis A virus participates in virion morphogenesis.

Authors:  Lisette Cohen; Danièle Bénichou; Annette Martin
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 6.  Evolutionary Origins of Enteric Hepatitis Viruses.

Authors:  Anna-Lena Sander; Victor Max Corman; Alexander N Lukashev; Jan Felix Drexler
Journal:  Cold Spring Harb Perspect Med       Date:  2018-12-03       Impact factor: 6.915

Review 7.  Inhibitor-Based Therapeutics for Treatment of Viral Hepatitis.

Authors:  Debajit Dey; Manidipa Banerjee
Journal:  J Clin Transl Hepatol       Date:  2016-09-25

8.  A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice.

Authors:  Kui Xiang; Yuri Kusov; Guan Ying; Wang Yan; Yi Shan; Wu Jinyuan; Yin Na; Zhou Yan; Li Hongjun; Sun Maosheng
Journal:  Viruses       Date:  2017-09-15       Impact factor: 5.048

9.  Hepatitis A virus (HAV) packaging size limit.

Authors:  Krishnamurthy Konduru; Siham M Nakamura; Gerardo G Kaplan
Journal:  Virol J       Date:  2009-11-18       Impact factor: 4.099

10.  Expression and stability of foreign epitopes introduced into 3A nonstructural protein of foot-and-mouth disease virus.

Authors:  Pinghua Li; Xingwen Bai; Yimei Cao; Chenghao Han; Zengjun Lu; Pu Sun; Hong Yin; Zaixin Liu
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.